Crossmark

In-transit metastatic cutaneous melanoma: current management and future directions

Published Online: 2021-05-17

Published Print: 2022-02

Authors

Patel, Ayushi

Carr, Michael J.

Sun, James

Zager, Jonathan S. https://orcid.org/0000-0002-6886-4468
License Information

Text and Data Mining valid from 2021-05-17

Version of Record valid from 2021-05-17
More Information

Article History

Received: 20 November 2020

Accepted: 22 April 2021

First Online: 17 May 2021

Declarations

:

: A.P and M.J.C have no conflicts of interest to disclose. J.S. has received research funding from Amgen. J.S.Z has advisory board relationships with Novartis, Sanofi/Regeneron, Merck; receives research funding from Amgen, Delcath Systems, Philogen, Provectus; consults for Castle Biosciences and Philogen, speaker’s bureau for Castle Biosciences, Pfizer and SunPharma. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

Document is current